AAAAAA

   
Results: 1-25 | 26-34
Results: 1-25/34

Authors: SHEEKEY D HOWE T SCARFFE JH MORGENSTERN GR CHANG J CHOPRA R
Citation: D. Sheekey et al., DONOR LYMPHOCYTE COLLECTIONS - USING THE COBE SPECTRA AUTOPBSC(TM) SYSTEM (VERSION-6), Bone marrow transplantation, 21, 1998, pp. 960-960

Authors: JONES ME FOX AJ BARNES AJ OPPENHEIM BA BALAGOPAL P MORGENSTERN GR SCARFFE JH
Citation: Me. Jones et al., PCR-ELISA FOR THE EARLY DIAGNOSIS OF INVASIVE PULMONARY ASPERGILLUS INFECTION IN NEUTROPENIC PATIENTS, Journal of Clinical Pathology, 51(9), 1998, pp. 652-656

Authors: ROBERTSON J NAGESH K JOWITT S KASPER C RYDER D SHEEKEY D CHANG J CHOPRA R MORGENSTERN GR TESTA NG SCARFFE JH
Citation: J. Robertson et al., COMPARISON OF STEM-CELL HARVESTS IN PATIENTS WITH ACUTE MYELOID-LEUKEMIA AND ACUTE LYMPHOBLASTIC-LEUKEMIA, British Journal of Haematology, 102(1), 1998, pp. 76-76

Authors: NAGESH K ROBERTSON J SHEEKEY D DOUGAL M CHANG J CHOPRA R MORGENSTERN GR TESTA NG SCARFFE JH
Citation: K. Nagesh et al., PERIPHERAL-BLOOD PROGENITOR-CELL (PBPC) HARVESTS IN MULTIPLE-MYELOMA - ANALYSIS OF FACTORS AFFECTING CONTENT AND EFFICACY, British Journal of Haematology, 101, 1998, pp. 282-282

Authors: NAGESH K ROBERTSON J HOWE T DOUGAL M CHANG J MORGENSTERN GR CHOPRA R SCARFFE JH
Citation: K. Nagesh et al., PERFORMANCE STATUS AT PRESENTATION PREDICTS FOR SURVIVAL AFTER AUTOLOGOUS PERIPHERAL-BLOOD PROGENITOR-CELL (PBPC) TRANSPLANTATION IN MULTIPLE-MYELOMA, British Journal of Haematology, 101, 1998, pp. 283-283

Authors: JOWITT SN CHANG J MORGENSTERN GR HOWE T RYDER WDJ TESTA NG SCARFFE JH
Citation: Sn. Jowitt et al., FACTORS WHICH AFFECT THE CFU-GM CONTENT OF THE PERIPHERAL-BLOOD HEMATOPOIETIC PROGENITOR-CELL HARVESTS IN PATIENTS WITH ACUTE MYELOID-LEUKEMIA, British Journal of Haematology, 100(4), 1998, pp. 688-694

Authors: DOBSON LS DUGGANKEEN M RADFORD JA STERN PL MORGENSTERN GR SCARFFE JH CROWTHER D
Citation: Ls. Dobson et al., CAN INTERLEUKIN-2 IMMEDIATELY AFTER HIGH-DOSE CHEMOTHERAPY WITH PERIPHERAL STEM-CELL TRANSPLANTATION IN PATIENTS WITH LYMPHOMA BE A SAFE AND EFFECTIVE WAY OF CAUSING A GRAFT-VERSUS-LYMPHOMA EFFECT, British Journal of Cancer, 78, 1998, pp. 51-51

Authors: DOBSON LS DUGGANKEEN M RADFORD JA STERN PL MORGENSTERN GR SCARFFE HJ CROWTHER D
Citation: Ls. Dobson et al., CYCLOSPORINE-A - CAN IT BE EFFECTIVELY GIVEN FROM THE DAY OF STEM-CELL RETURN IN PATIENTS WITH POOR-PROGNOSIS NON-HODGKINS-LYMPHOMA UNDERGOING HIGH-DOSE CHEMOTHERAPY WITH PERIPHERAL STEM-CELL TRANSPLANTATION, British Journal of Cancer, 78, 1998, pp. 52-52

Authors: LEE SM RADFORD JA DOBSON L HUQ T RYDER WDJ PETTENGELL R MORGENSTERN GR SCARFFE JH CROWTHER D
Citation: Sm. Lee et al., RECOMBINANT HUMAN GRANULOCYTE-COLONY-STIMULATING FACTOR (FILGRASTIM) FOLLOWING HIGH-DOSE CHEMOTHERAPY AND PERIPHERAL-BLOOD PROGENITOR-CELL RESCUE IN HIGH-GRADE NON-HODGKINS-LYMPHOMA - CLINICAL BENEFITS AT NO EXTRA COST, British Journal of Cancer, 77(8), 1998, pp. 1294-1299

Authors: FITZSIMMONS L SCARFFE JH MORGENSTERN GR
Citation: L. Fitzsimmons et al., EXTENDING THE ROLE OF THE CLINICAL NURSE SPECIALIST IN MEDICAL ONCOLOGY HAEMATOLOGY/, European journal of cancer, 33, 1997, pp. 1455-1455

Authors: LORIGAN PC WOODINGS PL MORGENSTERN GR SCARFFE JH
Citation: Pc. Lorigan et al., TURNER LYSIS SYNDROME, CASE-REPORT AND REVIEW OF THE LITERATURE - RESPONSE, Annals of oncology, 8(1), 1997, pp. 97-97

Authors: COUTINHO LH CHANG J BRERETON ML MORGENSTERN GR SCARFFE JH HARRISON CJ YIN JAL DARBYSHIRE PJ BURDACH S DEXTER TM TESTA NG
Citation: Lh. Coutinho et al., AUTOGRAFTING IN PHILADELPHIA (PH)-LEUKEMIA USING CULTURED MARROW - ANUPDATE OF A PILOT-STUDY( CHRONIC MYELOID), Bone marrow transplantation, 19(10), 1997, pp. 969-976

Authors: JOWITT SN CHANG J MORGENSTERN GR HOWE T RYDER D TESTA NG SCARFFE JH
Citation: Sn. Jowitt et al., FACTORS AFFECTING CFU-GM CONTENT OF PERIPHERAL-BLOOD HEMATOPOIETIC STEM-CELL HARVESTS IN PATIENTS WITH ACUTE MYELOID-LEUKEMIA, Blood, 90(10), 1997, pp. 4221-4221

Authors: PRENTICE AG MORGENSTERN GR PRENTICE HG ROPNER JE SCHEY SA WARNOCK DW
Citation: Ag. Prentice et al., FLUCONAZOLE-V ITRACONAZOLE PROPHYLAXIS IN NEUTROPENIA FOLLOWING THERAPY FOR HEMATOLOGICAL MALIGNANCY, Blood, 90(10), 1997, pp. 1865-1865

Authors: PRENTICE AG WARNOCK DW MORGENSTERN GR PRENTICE HG ROPNER JE SCHEY SA
Citation: Ag. Prentice et al., SERUM CONCENTRATIONS OF ITRACONAZOLE IN NEUTROPENIC PATIENTS RECEIVING ITRACONAZOLE CYCLODEXTRIN SOLUTION/, Blood, 90(10), 1997, pp. 2427-2427

Authors: LORIGAN PC WOODINGS PL MORGENSTERN GR SCARFFE JH
Citation: Pc. Lorigan et al., TUMOR LYSIS SYNDROME, CASE-REPORT AND REVIEW OF THE LITERATURE, Annals of oncology, 7(6), 1996, pp. 631-636

Authors: PETTENGELL R RADFORD JA MORGENSTERN GR SCARFFE JH HARRIS M WOLL PJ DEAKIN DP RYDER D WILKINSON PM CROWTHER D
Citation: R. Pettengell et al., SURVIVAL BENEFIT FRONT HIGH-DOSE THERAPY WITH AUTOLOGOUS BLOOD PROGENITOR-CELL TRANSPLANTATION IN POOR-PROGNOSIS NON-HODGKINS-LYMPHOMA, Journal of clinical oncology, 14(2), 1996, pp. 586-592

Authors: CHADWICK PR OPPENHEIM BA FOX A WOODFORD N MORGENSTERN GR SCARFFE JH
Citation: Pr. Chadwick et al., EPIDEMIOLOGY OF AN OUTBREAK DUE TO GLYCOPEPTIDE-RESISTANT ENTEROCOCCUS-FAECIUM ON A LEUKEMIA UNIT, The Journal of hospital infection, 34(3), 1996, pp. 171-182

Authors: BARNES AJ WARDLEY AM OPPENHEIM BA MORGENSTERN GR SCARFFE JH WARNOCK DW JOHNSON EM
Citation: Aj. Barnes et al., FATAL CANDIDA-TROPICALIS FUNGEMIA IN A LEUKEMIC PATIENT RECEIVING FLUCONAZOLE PROPHYLAXIS, The Journal of infection, 33(1), 1996, pp. 43-45

Authors: SCHEID C PETTENGELL R GHIELMINI M RADFORD JA MORGENSTERN GR STERN PL CROWTHER D
Citation: C. Scheid et al., TIME-COURSE OF THE RECOVERY OF CELLULAR IMMUNE FUNCTION AFTER HIGH-DOSE CHEMOTHERAPY AND PERIPHERAL-BLOOD PROGENITOR-CELL TRANSPLANTATION FOR HIGH-GRADE NON-HODGKINS-LYMPHOMA, Bone marrow transplantation, 15(6), 1995, pp. 901-906

Authors: JOHNSON PRE FITZSIMMONS CL CHANG J MORGENSTERN GR SCARFFE JH
Citation: Pre. Johnson et al., INFECTION AT THE TIME OF PERIPHERAL-BLOOD STEM-CELL LEUKAPHERESIS RESULTS IN REDUCED GRANULOCYTE-MACROPHAGE COLONY-FORMING UNIT YIELDS, British Journal of Haematology, 89(3), 1995, pp. 689-690

Authors: ANDERSON H SCARFFE JH RANSON M YOUNG R WIERINGA GS MORGENSTERN GR FITZSIMMONS L RYDER D
Citation: H. Anderson et al., VAD CHEMOTHERAPY AS REMISSION INDUCTION FOR MULTIPLE-MYELOMA, British Journal of Cancer, 71(2), 1995, pp. 326-330

Authors: COPPLESTONE JA WILLIAMSON P NORFOLK DR MORGENSTERN GR WIMPERIS JZ WILLIAMSON LM
Citation: Ja. Copplestone et al., WIDER BENEFITS OF LEUKODEPLETION OF BLOOD PRODUCTS, Blood, 86(1), 1995, pp. 409-410

Authors: VANHOEF MEHM BAUMANN I LANGE C LUFT T DEWYNTER EA RANSON M MORGENSTERN GR YVERS A DEXTER TM TESTA NG HOWELL A
Citation: Mehm. Vanhoef et al., DOSE-ESCALATING INDUCTION CHEMOTHERAPY SUPPORTED BY LENOGRASTIM PRECEDING HIGH-DOSE CONSOLIDATION CHEMOTHERAPY FOR ADVANCED BREAST-CANCER -SELECTION OF THE MOST ACCEPTABLE REGIMEN TO INDUCE MAXIMAL TUMOR RESPONSE AND INVESTIGATION OF THE OPTIMAL TIME TO COLLECT PERIPHERAL-BLOODPROGENITOR CELLS FOR HEMATOLOGICAL RESCUE AFTER HIGH-DOSE CONSOLIDATION CHEMOTHERAPY, Annals of oncology, 5(3), 1994, pp. 217-224

Authors: SCHEID C PETTENGELL R GHIELMINI M RADFORD JA MORGENSTERN GR CROWTHER D STERN PL
Citation: C. Scheid et al., RAPID IMMUNOLOGICAL RECONSTITUTION AFTER HIGH-DOSE CHEMOTHERAPY AND PERIPHERAL-BLOOD STEM-CELL TRANSPLANTATION IN HIGH-GRADE NON-HODGKIN-LYMPHOMA, Experimental hematology, 22(8), 1994, pp. 781-781
Risultati: 1-25 | 26-34